CN110236147A - 保健品组合物、其制备方法及其应用 - Google Patents
保健品组合物、其制备方法及其应用 Download PDFInfo
- Publication number
- CN110236147A CN110236147A CN201910378152.8A CN201910378152A CN110236147A CN 110236147 A CN110236147 A CN 110236147A CN 201910378152 A CN201910378152 A CN 201910378152A CN 110236147 A CN110236147 A CN 110236147A
- Authority
- CN
- China
- Prior art keywords
- halth
- care composition
- lemon
- care
- olive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 27
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 27
- 102000008186 Collagen Human genes 0.000 claims abstract description 26
- 108010035532 Collagen Proteins 0.000 claims abstract description 26
- 229920001436 collagen Polymers 0.000 claims abstract description 26
- 240000007817 Olea europaea Species 0.000 claims abstract description 23
- 235000007119 Ananas comosus Nutrition 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 29
- 241000234671 Ananas Species 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 11
- 206010003246 arthritis Diseases 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- 239000008101 lactose Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000036541 health Effects 0.000 claims description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 102000002734 Collagen Type VI Human genes 0.000 claims 1
- 108010043741 Collagen Type VI Proteins 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000002917 arthritic effect Effects 0.000 abstract description 3
- 241000050051 Chelone glabra Species 0.000 abstract description 2
- 241000894007 species Species 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 244000099147 Ananas comosus Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 7
- 201000008482 osteoarthritis Diseases 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001306 articular ligament Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003349 osteoarthritic effect Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明实施例公开了一种保健品组合物、其制备方法及其应用。所述保健品组合物的原料成分包括柠檬、Ⅱ型胶原蛋白、橄榄以及菠萝。其富含多种不同的种类成分。这些保健品组合物包含的天然活性成分之间的相互配伍,可以取得良好的保健治疗效果,能够有效的改善关节炎的一系列症状,并起到修复受损关节并提高关节强度的作用。
Description
技术领域
本发明涉及保健品技术领域,尤其涉及一种保健品组合物、其制备方法及其应用。
背景技术
随着社会的不断发展和人们生活水平的不断上升,人们形成了许多不健康的生活方式,由此可能引发与关节相关的一系列问题而对人们的造成严重的影响。
例如,人体的肥胖问题会诱发膝关节发生退行性骨关节炎,调查研究证实,肥胖女性发生膝关节退行性骨关节炎的发生率是正常体重的4倍。
还有资料显示,37岁时超过标准体重20%者,男性患关节病的危险性为标准体重者之1.5倍,女性为2.1倍。在以后36年中,60%超重者发生膝关节病,患严重膝关节病危险性男性增加到1.9倍,女性增加到3.2倍,提示肥胖可能是引发膝关节病的危险因素。
又例如不良的生活方式,长时间的久坐以及不重视锻炼会显著增加关节患病的风险,特别是长期伏案工作者、电脑工作者、教师、打字员、会计、办公室职员、长期手工业劳动者等,由于工作需要,长期关节活动减少,关节囊发生挛缩或长时间受压,造成周围微循环障碍,周围肌腱、韧带、关节软骨发生退变,增加了患病的几率。另外,长期负累运动,某些关节过度使用也会使骨性关节炎发生的危险性增加,造成关节损伤等风险。
在实现本发明的过程中,申请人发现现有技术存在如下技术问题:关节炎作为一种慢性疾病,产生许多的危害并严重的影响正常人的生活。但是,现有的医疗技术手段并不能很好的对关节炎起到抑制或者缓解的作用,难以根治已经发生炎症病变的关节。
发明内容
针对上述技术问题,本发明实施例提供了一种保健品组合物、其制备方法及其应用,以解决现在关节炎无法有效的得到治疗和缓解,会对正常人的生活造成严重影响的问题。
本发明实施例的第一方面提供保健品组合物。其中,所述保健品组合物的原料成分包括柠檬、Ⅱ型胶原蛋白、橄榄以及菠萝。
可选地,所述保健组合物的原料成分还包括:乳糖以及无水葡萄糖。
可选地,按重量百分比计算,所述原料成分的配比如下:
可选地,所述Ⅱ型胶原蛋白为非变性Ⅱ型胶原蛋白。
可选地,所述柠檬为柠檬粉。
可选地,按重量百分比计算,所述原料成分的配比如下:
可选地,所述保健品组合物为液态保健品,通过预设体积的水冲服。
可选地,所述预设体积为150毫升。
本发明实施例的第二方面提供一种如上所述的保健品组合物的制备方法。
其中,所述制备方法包括:
预处理柠檬、菠萝以及橄榄原料;干燥所述预处理后的柠檬、菠萝以及橄榄原料,制备获得对应的柠檬干粉、菠萝干粉以及橄榄干粉;在搅拌容器中,加入乳糖、无水葡萄糖以及Ⅱ型胶原蛋白并搅拌均匀;向所述搅拌容器中,加入柠檬干粉、菠萝干粉以及橄榄干粉;将所述混合均匀后的粉末使用设定比例的水溶解并封装。
本发明实施例第三方面提供了一种如上所述的保健品组合物在制备关节炎治疗药物中的应用。
本发明实施例的技术方案提供的保健品组合物,富含多种不同的种类成分。这些保健品组合物包含的天然活性成分之间的相互配伍,可以取得良好的保健治疗效果,能够有效的改善关节炎的一系列症状,并起到修复受损关节并提高关节强度的作用。
附图说明
图1为本发明实施例提供的保健品组合物的制备方法的一个实施例示意图。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
需要说明的是,当元件被表述“固定于”另一个元件,它可以直接在另一个元件上、或者其间可以存在一个或多个居中的元件。当一个元件被表述“连接”另一个元件,它可以是直接连接到另一个元件、或者其间可以存在一个或多个居中的元件。本说明书所使用的术语“垂直的”、“水平的”、“左”、“右”、“上”、“下”、“内”、“外”、“底部”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。此外,术语“第一”、“第二”等仅用于描述目的,而不能理解为指示或暗示相对重要性。
除非另有定义,本说明书所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本说明书中在本发明的说明书中所使用的术语只是为了描述具体的实施方式的目的,不是用于限制本发明。本说明书所使用的术语“和/或”包括一个或多个相关的所列项目的任意的和所有的组合。此外,下面所描述的本发明不同实施方式中所涉及的技术特征只要彼此之间未构成冲突就可以相互结合。
关节炎或者骨关节炎症是关节部位因炎症而造成红肿、疼痛等的病症。其容易造成剧烈疼痛,例如当邻近的神经根受压时,会引发局部疼痛、发僵,麻木等感觉。若炎症或骨刺压迫坐骨神经时,患肢会有剧烈的麻痛、灼痛、抽搐、窜痛并向整个下肢放射。
活动多、负重大的关节,如手指、膝、髋、颈椎、腰椎、踝等部位会受到关节炎的显著影响。因关节炎带来的一系列病症还会诱发脊椎侧弯、关节变形、胸椎弯曲、颈椎变形等并发症。严重者可能还会影响到心脏功能、肠道功能,并对心脑血管及高血压等产生影响。
本发明实施例提供了一种保健品组合物,具有对关节炎良好的保健效果,可以从根本上治疗关节炎的问题,不存在其他严重的副作用。在本实施例中,该保健品组合物的原料成分包括:柠檬、Ⅱ型胶原蛋白、橄榄以及菠萝。当然,根据实际情况的需要,还可以混合有其他的天然成分或者辅料(如乳糖和无水葡萄糖)等,以配合取得良好的使用效果。
其中,乳糖作为一种食品添加剂,具有调节胃酸,促进胃肠蠕动和消化腺分泌,帮助肠道中的乳酸菌繁殖和抑制腐败菌生长的作用。
柠檬能够帮助减肥塑身,其含有的多种营养物质能够帮助溶解消耗体内多余的脂肪,并且能够促进肠胃蠕动,加速身体排毒,消耗更多的热量。
部分营养物质溶于水后,会与钙质结合形成其他不易利用的物质,而柠檬中的成分可以帮助溶解这类物质,促进钙离子重新分解而加速被人体吸收利用。柠檬酸还能螯合钙,大大提高人体对钙的吸收率。
柠檬中还含有丰富的维生素,有机酸等物质。这些物质具有强效抗氧化作用,有利于皮肤的新陈代谢,特别是丰富的维生素C能够有效抑制黑色素的沉着,帮助美白肌肤。丰富的维生素C还能够有效增强人体免疫力,防止细菌入侵,帮助人体对抗流感,支气管炎等炎症。
柠檬中含有芳香挥发成分,能够帮助生津开胃。柠檬水中所含的有机酸等物质能够促进胃酸分泌,加强肠胃的消化功能。柠檬独特的香味能够有效刺激脑神经,从而让人保持较长时间的注意力,起到消除疲劳的作用。
Ⅱ型胶原蛋白是人体结缔组织的成分,是作为胶原蛋白的其中一种类型,其是透明软骨的主要成分,主要分布在骨关节等位置。胶原蛋白能主动参与细胞的迁移,分化和增殖代谢,既具有联结和营养功能,又具有支撑和保护作用。
胶原蛋白能使钙质和骨细胞相结合,避免钙质流失。人体肌肉的主要组成成分是肌纤蛋白和肌球蛋白,而细胞和细胞间需要靠胶原蛋白进行粘合,胶原蛋白分子形成的立体骨架可以帮助身体保持正确的姿势,并保持适当柔软度。
胶原蛋白中的甘氨酸含量丰富,不但在人体内能参与合成胶原,而且还能作为大脑细胞中的中枢神经抑制性递质,能对中枢神经产生镇静作用,对焦虑症,神经衰弱起到良好的辅助治疗作用。
活性胶原蛋白有极好的渗透性,它能透过角质层和皮肤上皮细胞结合,参与改善皮肤细胞代谢,加强皮肤中的胶原活性蛋白,保持角质层水分和纤维结构的完整性,增强血液循环,达到滋润皮肤的目的。当真皮中充满胶原蛋白时,皮肤细胞被撑起,既能保湿肌肤,又能达到舒展皱纹,淡化细纹的功效。当活性胶原蛋白进入肌肤底层后,与周围组织相互作用,能协助细胞制造成胶原蛋白,既能促使皮肤细胞正常增长,又能起到消炎和更新肌肤的作用。
从中医学角度,橄榄入肺经,有清肺利咽的作用,可以用于治疗慢性咽炎、风火喉痛引起的咳嗽、咽喉炎、感冒咳嗽、咽喉肿痛等疾病。橄榄味酸、涩,入胃经,具有生津止渴的作用,可以用于治疗暑热伤津、胃热口渴、萎缩胃炎等疾病。橄榄性甘、平,主入肺、胃经,有清热解毒的作用,可以用于治疗菌痢,癫痫,还可以用于解酒毒、毒草毒、河豚毒等。
橄榄提取物对半乳糖胺引起的肝细胞中毒有保护作用;亦能缓解四氯化碳对肝脏的损害,其还能兴奋唾液腺,使唾液分泌增加,有利于促进胃内食物消化。
菠萝中含有散发出诱人香气的酸丁酯,能刺激唾液分泌促进食欲,丰富的粗纤维,促进胃肠蠕动,帮助消化,从而促进食欲。而且含有大量的钾,钙,维生素C,维生素B,磷,铁,有机酸,烟酸以及糖分。钾,钙可以起到利尿消肿的功效。丰富的维生素B能滋养皮肤,有效的防止皮肤干燥。维生素C是一种抗氧化剂,可以抑制黑色素的形成。
菠萝蛋白酶是菠萝中独特的物质,又称蛋白质分解酵素。其具有分解蛋白质,溶解血管中的纤维蛋白及血栓,改善局部的血液循环的作用,还能有效去除牙齿表面的污垢,使牙齿亮白。菠萝含有大量植物纤维,有利于减少脂肪的吸收和促进肠胃蠕动,防止便秘。
无水葡萄糖是不含有结晶水的葡萄糖,为无色结晶或白色结晶性粉末。其作为一种易于被人体吸收的营养物质,可以添加到保健品组合物中,作为辅料使用。
具体的,为了便于使用,所述保健品组合物可以是液态的保健品。其按照一定的重量,独立封装进行保存,在使用时,于每天睡前直接开启密封包装服用,并配合使用150毫升体积的温水送服。
以下结合具体实例,详细描述该保健品组合物的具体组成和成分比例。在本实施例中,按重量百分比计算,所述原料成分的配比如下:乳糖50~60%;柠檬15~20%;Ⅱ型胶原蛋白5~15%;橄榄5~15%;菠萝3~5%;无水葡萄糖 3~5%。根据实际情况的需要,本领域技术人员可以在上述范围内选择搭配以获得所述第一组合物。
较佳的,按重量百分比计算,该保健品组合物由如下原料成分组成:乳糖58%;柠檬20%;Ⅱ型胶原蛋白9%;橄榄5%;菠萝4%;无水葡萄糖4%。令人惊喜的发现,采用上述组分配比的保健品组合物可以取得最佳的关节炎保健效果。
基于本发明实施例提供的保健品组合物。图1为本发明实施例提供的保健品组合物的制备方法。如图1所示,该保健品组合物可以采用如下方法步骤制备获得:
110、对原材料进行预处理。该预处理可以是任何合适的,对于原料的一种或者多种预处理过程,包括清洗和破碎为碎块等预处理操作。
120、干燥所述预处理后的柠檬、菠萝以及橄榄原料,制备获得对应的柠檬干粉、菠萝干粉以及橄榄干粉。
在一些实施例中,可以采用研磨或者真空干燥的方式,获得柠檬、橄榄以及菠萝对应的粉末。为了保证保健品组合物的口感和保健效果等,较佳的还可以在制备获得的柠檬干粉、菠萝干粉以及橄榄干粉加入搅拌容器前,通过特定目数的筛网进行筛选,以获得大小均匀的粉末颗粒。
130、在搅拌容器中,加入乳糖、无水葡萄糖以及Ⅱ型胶原蛋白。
在较佳实施例中,可以选择加入非变性Ⅱ型胶原蛋白。其具有Ⅱ型胶原蛋白的原始蛋白质构象,不会丧失Ⅱ型胶原蛋白原有的生理活性。
140、向所述搅拌容器中,加入柠檬干粉、菠萝干粉以及橄榄干粉,并搅拌均匀。
150、将所述混合均匀后的粉末使用设定比例的水溶解并封装。
可以理解的是,对本领域普通技术人员来说,可以根据本发明的技术方案及本发明构思加以等同替换或改变,而所有这些改变或替换都应属于本发明所附的权利要求的保护范围。
Claims (10)
1.一种保健品组合物,其特征在于,所述保健品组合物的原料成分包括柠檬、Ⅱ型胶原蛋白、橄榄以及菠萝。
2.根据权利要求1所述的保健品组合物,其特征在于,所述保健组合物的原料成分还包括:乳糖以及无水葡萄糖。
3.根据权利要求2所述的保健品组合物,其特征在于,按重量百分比计算,所述原料成分的配比如下:
4.根据权利要求1所述的保健品组合物,其特征在于,所述Ⅱ型胶原蛋白为非变性Ⅱ型胶原蛋白。
5.根据权利要求4所述的保健品组合物,其特征在于,所述柠檬为柠檬粉。
6.根据权利要求5所述的保健品组合物,其特征在于,按重量百分比计算,所述原料成分的配比如下:
7.根据权利要求1所述的保健品组合物,其特征在于,所述保健品组合物为液态保健品,通过预设体积的水冲服。
8.根据权利要求7所述的保健品组合物,其特征在于,所述预设体积为150毫升。
9.一种如权利要求1-8任一项所述的保健品组合物的制备方法,其特征在于,所述制备方法包括:
预处理柠檬、菠萝以及橄榄原料;
干燥所述预处理后的柠檬、菠萝以及橄榄原料,制备获得对应的柠檬干粉、菠萝干粉以及橄榄干粉;
在搅拌容器中,加入乳糖、无水葡萄糖以及Ⅱ型胶原蛋白并搅拌均匀;
向所述搅拌容器中,加入柠檬干粉、菠萝干粉以及橄榄干粉;
将所述混合均匀后的粉末使用设定比例的水溶解并封装。
10.一种如权利要求1-8任一项所述的保健品组合物在制备关节炎治疗药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910378152.8A CN110236147A (zh) | 2019-05-08 | 2019-05-08 | 保健品组合物、其制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910378152.8A CN110236147A (zh) | 2019-05-08 | 2019-05-08 | 保健品组合物、其制备方法及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110236147A true CN110236147A (zh) | 2019-09-17 |
Family
ID=67883665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910378152.8A Pending CN110236147A (zh) | 2019-05-08 | 2019-05-08 | 保健品组合物、其制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110236147A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108741099A (zh) * | 2018-06-11 | 2018-11-06 | 广州尚天诚品生物科技有限公司 | 一种有助于关节舒适的营养组合物及其制备方法和应用 |
CN108904784A (zh) * | 2018-06-29 | 2018-11-30 | 华北制药河北华诺有限公司 | 一种牛骨胶原蛋白肽组合物及其制备方法 |
CN109156829A (zh) * | 2018-09-12 | 2019-01-08 | 广州市顺芝堂生物科技有限公司 | 一种鱼胶原蛋白组合物及其制备方法和应用 |
CN109567157A (zh) * | 2018-10-23 | 2019-04-05 | 北京同仁堂健康药业股份有限公司 | 一种用于改善骨关节健康的组合物及其制备方法 |
CN109601680A (zh) * | 2019-01-17 | 2019-04-12 | 云南龙布瑞生物科技有限公司 | 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 |
-
2019
- 2019-05-08 CN CN201910378152.8A patent/CN110236147A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108741099A (zh) * | 2018-06-11 | 2018-11-06 | 广州尚天诚品生物科技有限公司 | 一种有助于关节舒适的营养组合物及其制备方法和应用 |
CN108904784A (zh) * | 2018-06-29 | 2018-11-30 | 华北制药河北华诺有限公司 | 一种牛骨胶原蛋白肽组合物及其制备方法 |
CN109156829A (zh) * | 2018-09-12 | 2019-01-08 | 广州市顺芝堂生物科技有限公司 | 一种鱼胶原蛋白组合物及其制备方法和应用 |
CN109567157A (zh) * | 2018-10-23 | 2019-04-05 | 北京同仁堂健康药业股份有限公司 | 一种用于改善骨关节健康的组合物及其制备方法 |
CN109601680A (zh) * | 2019-01-17 | 2019-04-12 | 云南龙布瑞生物科技有限公司 | 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mujoriya et al. | A study on wheat grass and its nutritional value | |
CN101248882B (zh) | 一种具有促进骨骼和骨关节健康的营养食品 | |
KR101645917B1 (ko) | 관절건강에 도움이 되는 한약재 및 그의 제조방법 | |
CN100387217C (zh) | 酵素健身浴粉末及制备方法 | |
JP2006290784A (ja) | 血流悪化防止作用を有する組成物、及びそれを含有する飲食品 | |
CN101322551A (zh) | 一种用于增加骨密度和修复关节软骨的组合物 | |
CN104116022B (zh) | 用于改善妇女更年期综合症的复合保健食品及其制备方法 | |
KR101428363B1 (ko) | 근골격계 염증질환 개선 한방조성물의 제조방법 | |
CN102379391B (zh) | 松花粉葡聚糖纳豆保健食品的制备 | |
CN105852061A (zh) | 一种百香果酵素及其制备方法 | |
CN110236147A (zh) | 保健品组合物、其制备方法及其应用 | |
Khan et al. | A Review-Benefits of Panchgavya therapy (Cowpathy) for health of humans | |
CN101416734A (zh) | 一种改善骨骼及关节功能的保健品及其制备方法 | |
CN109464651A (zh) | 一种软骨代谢异常疾病改善用健康食品及药品组合物 | |
CN102524800A (zh) | 一种复合黄瓜籽粉及其制备方法 | |
CN108888751B (zh) | 一种用于治疗和预防关节炎的组合物及其制备方法 | |
EP3381457A1 (de) | Physiologisch aktive zubreitung umfassend n-acetyl-glukosamin zur behandlung von rückenschmerzen | |
CN103919132B (zh) | 含蚂蚁多肽、壳聚糖的蚂蚁粉的制备方法 | |
CN102100759A (zh) | 一种补益肝肾治疗骨质增生的中药组合物 | |
CN1058630C (zh) | 一种治疗男性性功能低下的中药及其制作工艺 | |
CN109172810A (zh) | 一种防治头颈癌的生物组合物 | |
US11090365B2 (en) | Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs | |
CN108552528A (zh) | 一种保护血管及增强免疫力猕猴桃酵素及其生产方法 | |
CN1105826A (zh) | 全营养补钙液的制作方法 | |
CN107050257A (zh) | 一种中药调理膏剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |